1. Ryoo N, Son H, Kim JH, Bae DW, An JY. Guillain–Barré syndrome after COVID-19 infection in Korea: a case series. J Korean Med Sci. 2024; 39(5):e48. PMID:
38317448.
2. Sawada D, Fujii K, Misawa S, Shiohama T, Fukuhara T, Fujita M, et al. Bilateral spinal anterior horn lesions in acute motor axonal neuropathy. Brain Dev. 2018; 40(9):830–832. PMID:
29853225.
3. Abdel-Mannan O, D’Argenzio L, Pitt M, D’Arco F, Bhate S, Hacohen Y, et al. Two cases of Guillain-Barré syndrome variants presenting with dysautonomia. Child Neurol Open. 2019; 6:2329048X19856778.
4. Guo Y, Dong L, Gong A, Zhang J, Jing L, Ding T, et al. Damage to the blood\xe2\x80\x91brain barrier and activation of neuroinflammation by focal cerebral ischemia under hyperglycemic condition. Int J Mol Med. 2021; 48(1):142. PMID:
34080644.
5. Fautsch KJ, Block DR, Graff-Radford J, Wang F, Craver EC, Hodge DO, et al. Population-based evaluation of total protein in cerebrospinal fluid. Mayo Clin Proc. 2023; 98(2):239–251. PMID:
36737114.
6. De Sanctis P, Doneddu PE, Viganò L, Selmi C, Nobile-Orazio E. Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review. Eur J Neurol. 2020; 27(11):2361–2370. PMID:
32757404.
7. Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022; 65(6):E31–E32. PMID:
35385125.
8. Biassoni E, Assini A, Gandoglia I, Benedetti L, Boni S, Pontali E, et al. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation. J Neurovirol. 2021; 27(4):662–665. PMID:
34341959.
9. Carmona-Torre F, Mínguez-Olaondo A, López-Bravo A, Tijero B, Grozeva V, Walcker M, et al. Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies. Front Neurol. 2022; 13:886609. PMID:
35720084.
10. Eldokla AM, Mohamed-Hussein AA, Fouad AM, Abdelnaser MG, Ali ST, Makhlouf NA, et al. Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: a cross-sectional study. Ann Clin Transl Neurol. 2022; 9(6):778–785. PMID:
35393771.